Literature DB >> 24008618

Covert warfare against the immune system: decoy capsids, stealth genomes, and suppressors.

Brad E Hoffman1, Roland W Herzog.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24008618      PMCID： PMC3776640          DOI： 10.1038/mt.2013.176

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  15 in total

1.  The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver.

Authors:  Ashley T Martino; Masataka Suzuki; David M Markusic; Irene Zolotukhin; Renee C Ryals; Babak Moghimi; Hildegund C J Ertl; Daniel A Muruve; Brendan Lee; Roland W Herzog
Journal:  Blood       Date:  2011-04-07       Impact factor: 22.113

2.  A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8.

Authors:  Virginie Monteilhet; Samir Saheb; Sylvie Boutin; Christian Leborgne; Philippe Veron; Marie-Françoise Montus; Philippe Moullier; Olivier Benveniste; Carole Masurier
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

3.  Systemic administration of AAV8-α-galactosidase A induces humoral tolerance in nonhuman primates despite low hepatic expression.

Authors:  Jennifer B Nietupski; Gregory D Hurlbut; Robin J Ziegler; Qiuming Chu; Bradley L Hodges; Karen M Ashe; Mark Bree; Seng H Cheng; Richard J Gregory; John Marshall; Ronald K Scheule
Journal:  Mol Ther       Date:  2011-06-28       Impact factor: 11.454

Review 4.  The complex and evolving story of T cell activation to AAV vector-encoded transgene products.

Authors:  Lauren E Mays; James M Wilson
Journal:  Mol Ther       Date:  2010-11-30       Impact factor: 11.454

5.  Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates.

Authors:  Hua Li; Marcio O Lasaro; Bei Jia; Shih Wen Lin; Larissa H Haut; Katherine A High; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2011-05-17       Impact factor: 11.454

6.  The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice.

Authors:  Jiangao Zhu; Xiaopei Huang; Yiping Yang
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

7.  AAV vector biology in primates: finding the missing link?

Authors:  Roland W Herzog; Andrew M Davidoff; David M Markusic; Amit C Nathwani
Journal:  Mol Ther       Date:  2011-11       Impact factor: 11.454

8.  Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes.

Authors:  Daniel J Hui; Etiena Basner-Tschakarjan; Yifeng Chen; Robert J Davidson; George Buchlis; Mustafa Yazicioglu; Gary C Pien; Jonathan D Finn; Virginia Haurigot; Alex Tai; David W Scott; Leslie P Cousens; Shangzhen Zhou; Anne S De Groot; Federico Mingozzi
Journal:  Mol Ther       Date:  2013-07-16       Impact factor: 11.454

9.  MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV.

Authors:  Muriel Sudres; Séverine Ciré; Virginie Vasseur; Léa Brault; Sylvie Da Rocha; Florence Boisgérault; Christine Le Bec; David Alexandre Gross; Véronique Blouin; Bernard Ryffel; Anne Galy
Journal:  Mol Ther       Date:  2012-05-29       Impact factor: 11.454

10.  Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.

Authors:  Amit C Nathwani; Edward G D Tuddenham; Savita Rangarajan; Cecilia Rosales; Jenny McIntosh; David C Linch; Pratima Chowdary; Anne Riddell; Arnulfo Jaquilmac Pie; Chris Harrington; James O'Beirne; Keith Smith; John Pasi; Bertil Glader; Pradip Rustagi; Catherine Y C Ng; Mark A Kay; Junfang Zhou; Yunyu Spence; Christopher L Morton; James Allay; John Coleman; Susan Sleep; John M Cunningham; Deokumar Srivastava; Etiena Basner-Tschakarjan; Federico Mingozzi; Katherine A High; John T Gray; Ulrike M Reiss; Arthur W Nienhuis; Andrew M Davidoff
Journal:  N Engl J Med       Date:  2011-12-10       Impact factor: 176.079
View more
  7 in total

1.  AAV empty capsids: for better or for worse?

Authors:  J Fraser Wright
Journal:  Mol Ther       Date:  2014-01       Impact factor: 11.454

Review 2.  Gene Therapy for Hemophilia.

Authors:  Arthur W Nienhuis; Amit C Nathwani; Andrew M Davidoff
Journal:  Mol Ther       Date:  2017-04-11       Impact factor: 11.454

Review 3.  Surgical Strikes on Host Defenses: Role of the Viral Protease Activity in Innate Immune Antagonism.

Authors:  Chue Vin Chin; Mohsan Saeed
Journal:  Pathogens       Date:  2022-04-28

4.  Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleases.

Authors:  Pavitra Roychoudhury; Harshana S De Silva Feelixge; Harlan L Pietz; Daniel Stone; Keith R Jerome; Joshua T Schiffer
Journal:  J Antimicrob Chemother       Date:  2016-04-18       Impact factor: 5.790

Review 5.  Novel therapies and current clinical progress in hemophilia A.

Authors:  Pauline Balkaransingh; Guy Young
Journal:  Ther Adv Hematol       Date:  2017-12-28

6.  Development of Gene Transfer for Induction of Antigen-specific Tolerance.

Authors:  Brandon K Sack; Roland W Herzog; Cox Terhorst; David M Markusic
Journal:  Mol Ther Methods Clin Dev       Date:  2014-04-30       Impact factor: 6.698

Review 7.  Clinical development of gene therapy: results and lessons from recent successes.

Authors:  Sandeep Rp Kumar; David M Markusic; Moanaro Biswas; Katherine A High; Roland W Herzog
Journal:  Mol Ther Methods Clin Dev       Date:  2016-05-25       Impact factor: 6.698
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.